McGill University Health Centre/Research Institute of the McGill University Health Centre: Diabetes Mellitus, Type 1 trials

The registry lists 16 Diabetes Mellitus, Type 1 studies with McGill University Health Centre/Research Institute of the McGill University Health Centre as lead sponsor. 7 are open to participants now and 0 have results posted.

Phase 2 6Phase 3 6Phase 4 1No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Lean Mass Changes With Semaglutide in Adults With Type 1 Diabetes and Overweight/Obesity.RecruitingNCT07891156Phase 2/3
• A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood SugarRecruitingNCT07284511Phase 2/3
• A Clinical Trial to Evaluate The Effects of Semaglutide and Empagliflozin Combined to Automated Insulin Delivery on Diabetes Control in Adults Living With Type 1 DiabetesRecruitingNCT06894784Phase 3
• Alleviating Carbohydrate Counting for Patients with Type-1 Diabetes Using a Closed Loop System with Weekly Subcutaneous SemaglutideRecruitingNCT06387199Phase 2/3
• A Fully Automated Lyumjev and Pramlintide Delivery System for Adults With Type 1 DiabetesRecruitingNCT06046417Phase 2/3
• A Trial to Compare Automated Lyumjev Delivery With Carbohydrate Counting, Qualitative Meal-size Estimation, and Meal Detection in Type 1 DiabetesRecruitingNCT06021158Phase 2
• Monogenic Diabetes Misdiagnosed as Type 1RecruitingNCT03988764
• Effect of Artificial Sweetener (AFS) on Glucose Metabolism in Patients With Type 1 Diabetes (T1D)TerminatedNCT06315725
• Effectiveness of Empagliflozin Added to Automated Insulin Delivery (AID) Systems in Adults With Type 1 Diabetes With Sub-optimal Glycemic OutcomesStatus unknownNCT06021145Phase 4
• Group Education Trial to Improve Transition for Parents of Adolescents With T1DCompletedNCT05445284Not applicable
• Weekly Subcutaneous Semaglutide as Adjunct to Closed-loop Therapy in Type 1 Diabetes CareCompletedNCT05205928Phase 2/3
• A Fully-closed Loop, Pramlintide and Insulin, Artificial Pancreas Clinical Trial for Adults With Type 1 DiabetesCompletedNCT05199714Not applicable
• Group Education Trial to Improve Transition in Type 1 DiabetesCompletedNCT03703440Not applicable
• Insulin-based Strategies to Prevent Hypoglycemia During ExerciseStatus unknownNCT03349489Not applicable
• Circulating Extracellular Vesicles Released by Human Islets of LangerhansStatus unknownNCT03106246
• STigma and Its Impact on Glucose Control aMong Youth With diAbetes, a Canada-Wide StudyCompletedNCT02796248